Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: A functional magnetic resonance imaging study

Tomohiro Nakao, Akiko Nakagawa, Takashi Yoshiura, Eriko Nakatani, Maiko Nabeyama, Chika Yoshizato, Akiko Kudoh, Kyoko Tada, Kazuko Yoshioka, Midori Kawamoto, Osamu Togao, Shigenobu Kanba

Research output: Contribution to journalArticle

215 Citations (Scopus)

Abstract

Background: Functional neuroimaging studies have implicated hyperactivity of the frontal cortex in obsessive-compulsive disorder (OCD); however, relationships between abnormal brain activity, clinical improvement, and neuropsychological function have not been clarified in OCD. To clarify the pathophysiology of this disorder, regional changes in brain function were examined during administration of cognitive and symptom provocation tasks in patients with OCD before and after treatment. Methods: Ten outpatients with OCD participated in the study. Functional magnetic resonance imaging (fMRI) was performed before and after treatment. Stroop and symptom provocation tasks were administered during fMRI. Each patient was randomly allocated to receive either pharmacotherapy with fluvoxamine 200 mg/day (n = 4) or behavior therapy (n = 6) for 12 weeks. Results: After 12-week treatment, mean (± SD) total score on the Yale-Brown Obsessive-Compulsive Scale decreased from 29.00 ± 3.59 to 14.60 ± 9.22, representing symptomatic improvement from moderate to mild. After symptom improvement, symptom provocation-related activation in the orbitofrontal, dorsolateral-prefrontal, and anterior cingulate cortices decreased. Conversely, Stroop task-related activation in the parietal cortex and cerebellum increased. Conclusions: After improvement of OCD with either fluvoxamine or behavioral therapy, hyperactivation of the frontal lobe related to a symptom-provocative state decreases, and posterior brain activity related to action-monitoring function increases.

Original languageEnglish
Pages (from-to)901-910
Number of pages10
JournalBiological Psychiatry
Volume57
Issue number8
DOIs
Publication statusPublished - Apr 15 2005

Fingerprint

Obsessive-Compulsive Disorder
Magnetic Resonance Imaging
Brain
Fluvoxamine
Frontal Lobe
Neurobehavioral Manifestations
Parietal Lobe
Functional Neuroimaging
Behavior Therapy
Gyrus Cinguli
Therapeutics
Cerebellum
Outpatients
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Biological Psychiatry

Cite this

Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement : A functional magnetic resonance imaging study. / Nakao, Tomohiro; Nakagawa, Akiko; Yoshiura, Takashi; Nakatani, Eriko; Nabeyama, Maiko; Yoshizato, Chika; Kudoh, Akiko; Tada, Kyoko; Yoshioka, Kazuko; Kawamoto, Midori; Togao, Osamu; Kanba, Shigenobu.

In: Biological Psychiatry, Vol. 57, No. 8, 15.04.2005, p. 901-910.

Research output: Contribution to journalArticle

Nakao, Tomohiro ; Nakagawa, Akiko ; Yoshiura, Takashi ; Nakatani, Eriko ; Nabeyama, Maiko ; Yoshizato, Chika ; Kudoh, Akiko ; Tada, Kyoko ; Yoshioka, Kazuko ; Kawamoto, Midori ; Togao, Osamu ; Kanba, Shigenobu. / Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement : A functional magnetic resonance imaging study. In: Biological Psychiatry. 2005 ; Vol. 57, No. 8. pp. 901-910.
@article{8431258f46854b40a9ddc3c78e88fbaa,
title = "Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: A functional magnetic resonance imaging study",
abstract = "Background: Functional neuroimaging studies have implicated hyperactivity of the frontal cortex in obsessive-compulsive disorder (OCD); however, relationships between abnormal brain activity, clinical improvement, and neuropsychological function have not been clarified in OCD. To clarify the pathophysiology of this disorder, regional changes in brain function were examined during administration of cognitive and symptom provocation tasks in patients with OCD before and after treatment. Methods: Ten outpatients with OCD participated in the study. Functional magnetic resonance imaging (fMRI) was performed before and after treatment. Stroop and symptom provocation tasks were administered during fMRI. Each patient was randomly allocated to receive either pharmacotherapy with fluvoxamine 200 mg/day (n = 4) or behavior therapy (n = 6) for 12 weeks. Results: After 12-week treatment, mean (± SD) total score on the Yale-Brown Obsessive-Compulsive Scale decreased from 29.00 ± 3.59 to 14.60 ± 9.22, representing symptomatic improvement from moderate to mild. After symptom improvement, symptom provocation-related activation in the orbitofrontal, dorsolateral-prefrontal, and anterior cingulate cortices decreased. Conversely, Stroop task-related activation in the parietal cortex and cerebellum increased. Conclusions: After improvement of OCD with either fluvoxamine or behavioral therapy, hyperactivation of the frontal lobe related to a symptom-provocative state decreases, and posterior brain activity related to action-monitoring function increases.",
author = "Tomohiro Nakao and Akiko Nakagawa and Takashi Yoshiura and Eriko Nakatani and Maiko Nabeyama and Chika Yoshizato and Akiko Kudoh and Kyoko Tada and Kazuko Yoshioka and Midori Kawamoto and Osamu Togao and Shigenobu Kanba",
year = "2005",
month = "4",
day = "15",
doi = "10.1016/j.biopsych.2004.12.039",
language = "English",
volume = "57",
pages = "901--910",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "8",

}

TY - JOUR

T1 - Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement

T2 - A functional magnetic resonance imaging study

AU - Nakao, Tomohiro

AU - Nakagawa, Akiko

AU - Yoshiura, Takashi

AU - Nakatani, Eriko

AU - Nabeyama, Maiko

AU - Yoshizato, Chika

AU - Kudoh, Akiko

AU - Tada, Kyoko

AU - Yoshioka, Kazuko

AU - Kawamoto, Midori

AU - Togao, Osamu

AU - Kanba, Shigenobu

PY - 2005/4/15

Y1 - 2005/4/15

N2 - Background: Functional neuroimaging studies have implicated hyperactivity of the frontal cortex in obsessive-compulsive disorder (OCD); however, relationships between abnormal brain activity, clinical improvement, and neuropsychological function have not been clarified in OCD. To clarify the pathophysiology of this disorder, regional changes in brain function were examined during administration of cognitive and symptom provocation tasks in patients with OCD before and after treatment. Methods: Ten outpatients with OCD participated in the study. Functional magnetic resonance imaging (fMRI) was performed before and after treatment. Stroop and symptom provocation tasks were administered during fMRI. Each patient was randomly allocated to receive either pharmacotherapy with fluvoxamine 200 mg/day (n = 4) or behavior therapy (n = 6) for 12 weeks. Results: After 12-week treatment, mean (± SD) total score on the Yale-Brown Obsessive-Compulsive Scale decreased from 29.00 ± 3.59 to 14.60 ± 9.22, representing symptomatic improvement from moderate to mild. After symptom improvement, symptom provocation-related activation in the orbitofrontal, dorsolateral-prefrontal, and anterior cingulate cortices decreased. Conversely, Stroop task-related activation in the parietal cortex and cerebellum increased. Conclusions: After improvement of OCD with either fluvoxamine or behavioral therapy, hyperactivation of the frontal lobe related to a symptom-provocative state decreases, and posterior brain activity related to action-monitoring function increases.

AB - Background: Functional neuroimaging studies have implicated hyperactivity of the frontal cortex in obsessive-compulsive disorder (OCD); however, relationships between abnormal brain activity, clinical improvement, and neuropsychological function have not been clarified in OCD. To clarify the pathophysiology of this disorder, regional changes in brain function were examined during administration of cognitive and symptom provocation tasks in patients with OCD before and after treatment. Methods: Ten outpatients with OCD participated in the study. Functional magnetic resonance imaging (fMRI) was performed before and after treatment. Stroop and symptom provocation tasks were administered during fMRI. Each patient was randomly allocated to receive either pharmacotherapy with fluvoxamine 200 mg/day (n = 4) or behavior therapy (n = 6) for 12 weeks. Results: After 12-week treatment, mean (± SD) total score on the Yale-Brown Obsessive-Compulsive Scale decreased from 29.00 ± 3.59 to 14.60 ± 9.22, representing symptomatic improvement from moderate to mild. After symptom improvement, symptom provocation-related activation in the orbitofrontal, dorsolateral-prefrontal, and anterior cingulate cortices decreased. Conversely, Stroop task-related activation in the parietal cortex and cerebellum increased. Conclusions: After improvement of OCD with either fluvoxamine or behavioral therapy, hyperactivation of the frontal lobe related to a symptom-provocative state decreases, and posterior brain activity related to action-monitoring function increases.

UR - http://www.scopus.com/inward/record.url?scp=20144389554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144389554&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2004.12.039

DO - 10.1016/j.biopsych.2004.12.039

M3 - Article

C2 - 15820711

AN - SCOPUS:20144389554

VL - 57

SP - 901

EP - 910

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 8

ER -